๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intracerebral leukemic mass in acute myelogenous leukemia

โœ Scribed by Kazuhiro Fukui; Ikuzo Iguchi; Akira Kito; Midori Ohba

Book ID
104651055
Publisher
Springer US
Year
1992
Tongue
English
Weight
942 KB
Volume
12
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

โœฆ Synopsis

Leukemic intracranial space occupying lesions are rare. A 69 year old man with acute myelogenous leukemia was found to have an intracranial leukemic mass at the time of his remission period. Computed tomography and magnetic resonance imaging study demonstrated a large irregular mass in the right temporal lobe. After total removal of the tumor, the patient was treated with whole brain irradiation and intrathecal chemotherapy. After surviving for 7 months, the patient expired of hematologic relapse.

๐Ÿ“œ SIMILAR VOLUMES

Flt3 in acute myelogenous leukemia
Flt3 in acute myelogenous leukemia
โœ Ioannis A. Voutsadakis ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Springer US ๐ŸŒ English โš– 110 KB
Early deaths in acute myelogenous leukem
Early deaths in acute myelogenous leukemia
โœ Dr. I. E. Smith; R. Powles; H. MacD. Clink; B. Jameson; H. E. M. Kay; T. J. McEl ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 451 KB ๐Ÿ‘ 2 views
Molecular targets in acute myelogenous l
Molecular targets in acute myelogenous leukemia
โœ Derek L Stirewalt; Soheil Meshinchi; Jerald P Radich ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 239 KB

Acute myeloid leukemia (AML) remains the most common form of leukemia and the most common cause of leukemia death. Although conventional chemotherapy can cure between 25 and 45% of AML patients, most patients will either die of relapse or die from the complications associated with treatment. Thus, m